Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.33
DOW's Cash to Debt is ranked higher than
50% of the 989 Companies
in the Global Chemicals industry.

( Industry Median: 0.68 vs. DOW: 0.33 )
DOW' s 10-Year Cash to Debt Range
Min: 0.02   Max: 0.53
Current: 0.33

0.02
0.53
Equity to Asset 0.39
DOW's Equity to Asset is ranked lower than
54% of the 989 Companies
in the Global Chemicals industry.

( Industry Median: 0.56 vs. DOW: 0.39 )
DOW' s 10-Year Equity to Asset Range
Min: 0.19   Max: 0.4
Current: 0.39

0.19
0.4
Interest Coverage 3.88
DOW's Interest Coverage is ranked lower than
56% of the 660 Companies
in the Global Chemicals industry.

( Industry Median: 16.65 vs. DOW: 3.88 )
DOW' s 10-Year Interest Coverage Range
Min: 0.31   Max: 8.82
Current: 3.88

0.31
8.82
F-Score: 7
Z-Score: 2.55
M-Score: -2.95
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 7.49
DOW's Operating margin (%) is ranked higher than
76% of the 980 Companies
in the Global Chemicals industry.

( Industry Median: 5.73 vs. DOW: 7.49 )
DOW' s 10-Year Operating margin (%) Range
Min: -1.4   Max: 18.96
Current: 7.49

-1.4
18.96
Net-margin (%) 8.39
DOW's Net-margin (%) is ranked higher than
84% of the 980 Companies
in the Global Chemicals industry.

( Industry Median: 3.76 vs. DOW: 8.39 )
DOW' s 10-Year Net-margin (%) Range
Min: -1.38   Max: 10.25
Current: 8.39

-1.38
10.25
ROE (%) 17.80
DOW's ROE (%) is ranked higher than
94% of the 972 Companies
in the Global Chemicals industry.

( Industry Median: 6.54 vs. DOW: 17.80 )
DOW' s 10-Year ROE (%) Range
Min: -4.43   Max: 29.46
Current: 17.8

-4.43
29.46
ROA (%) 6.89
DOW's ROA (%) is ranked higher than
86% of the 985 Companies
in the Global Chemicals industry.

( Industry Median: 3.38 vs. DOW: 6.89 )
DOW' s 10-Year ROA (%) Range
Min: -1.08   Max: 9.83
Current: 6.89

-1.08
9.83
ROC (Joel Greenblatt) (%) 16.66
DOW's ROC (Joel Greenblatt) (%) is ranked higher than
82% of the 981 Companies
in the Global Chemicals industry.

( Industry Median: 10.91 vs. DOW: 16.66 )
DOW' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -2.27   Max: 35.06
Current: 16.66

-2.27
35.06
Revenue Growth (%) -2.00
DOW's Revenue Growth (%) is ranked lower than
52% of the 789 Companies
in the Global Chemicals industry.

( Industry Median: 5.20 vs. DOW: -2.00 )
DOW' s 10-Year Revenue Growth (%) Range
Min: -5.5   Max: 16.1
Current: -2

-5.5
16.1
EBITDA Growth (%) 9.00
DOW's EBITDA Growth (%) is ranked higher than
77% of the 681 Companies
in the Global Chemicals industry.

( Industry Median: 4.20 vs. DOW: 9.00 )
DOW' s 10-Year EBITDA Growth (%) Range
Min: -27.9   Max: 63
Current: 9

-27.9
63
EPS Growth (%) 26.10
DOW's EPS Growth (%) is ranked higher than
87% of the 630 Companies
in the Global Chemicals industry.

( Industry Median: 3.40 vs. DOW: 26.10 )
DOW' s 10-Year EPS Growth (%) Range
Min: -61.4   Max: 52
Current: 26.1

-61.4
52
» DOW's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2013

DOW Guru Trades in Q1 2013

T Boone Pickens 3,800 sh (New)
John Burbank 988,824 sh (New)
Signature Select Canadian Fund 173,500 sh (New)
Manning & Napier Advisors, Inc 84,941 sh (+4.78%)
Jeff Auxier 99,572 sh (+1.63%)
Pioneer Investments Sold Out
Joel Greenblatt Sold Out
Dodge & Cox 29,788,219 sh (-0.1%)
Ken Fisher 6,604 sh (-0.75%)
PRIMECAP Management 1,516,100 sh (-1.44%)
Steven Cohen 1,771,140 sh (-18.51%)
Charles Brandes 263,764 sh (-21.95%)
» More
Q2 2013

DOW Guru Trades in Q2 2013

Pioneer Investments 14,261 sh (New)
Caxton Associates 202,273 sh (New)
Jean-Marie Eveillard 1,438,852 sh (New)
Joel Greenblatt 36,364 sh (New)
T Boone Pickens 7,300 sh (+92.11%)
PRIMECAP Management 1,683,500 sh (+11.04%)
Charles Brandes Sold Out
Steven Cohen Sold Out
John Burbank Sold Out
Ken Fisher Sold Out
Jeff Auxier 99,472 sh (-0.1%)
Dodge & Cox 29,594,622 sh (-0.65%)
Manning & Napier Advisors, Inc 11,217 sh (-86.79%)
» More
Q3 2013

DOW Guru Trades in Q3 2013

Ray Dalio 43,208 sh (New)
George Soros 385,228 sh (New)
John Burbank 40,000 sh (New)
Steven Cohen 152,754 sh (New)
Pioneer Investments 134,668 sh (+844.31%)
Signature Select Canadian Fund 198,200 sh (+14.24%)
Joel Greenblatt 40,522 sh (+11.43%)
PRIMECAP Management 1,714,000 sh (+1.81%)
Caxton Associates Sold Out
Jean-Marie Eveillard Sold Out
T Boone Pickens Sold Out
Jeff Auxier 98,772 sh (-0.7%)
Dodge & Cox 28,997,741 sh (-2.02%)
Manning & Napier Advisors, Inc 6,651 sh (-40.71%)
» More
Q4 2013

DOW Guru Trades in Q4 2013

Daniel Loeb 7,725,000 sh (New)
Ken Fisher 7,394 sh (New)
Paul Tudor Jones 40,000 sh (New)
Joel Greenblatt 91,573 sh (+125.98%)
Pioneer Investments 289,943 sh (+115.3%)
John Burbank 55,000 sh (+37.5%)
Louis Moore Bacon 100,000 sh (unchged)
Daniel Loeb 23,000 sh (unchged)
Manning & Napier Advisors, Inc Sold Out
Jeff Auxier 98,722 sh (-0.05%)
PRIMECAP Management 1,679,605 sh (-2.01%)
Steven Cohen 128,017 sh (-16.19%)
George Soros 265,890 sh (-30.98%)
Dodge & Cox 17,435,724 sh (-39.87%)
Ray Dalio 15,308 sh (-64.57%)
» More
» Details

Insider Trades

Latest Guru Trades with DOW

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Daniel Loeb 2013-12-31 New Buy5.9%$38.4 - $44.86 $ 48.7220%7725000
Dodge & Cox 2013-12-31 Reduce -39.87%0.52%$38.4 - $44.86 $ 48.7220%17435724
George Soros 2013-12-31 Reduce -30.98%0.05%$38.4 - $44.86 $ 48.7220%265890
Joel Greenblatt 2013-12-31 Add 125.98%0.05%$38.4 - $44.86 $ 48.7220%91573
John Burbank 2013-12-31 Add 37.5%0.02%$38.4 - $44.86 $ 48.7220%55000
Ray Dalio 2013-12-31 Reduce -64.57%0.01%$38.4 - $44.86 $ 48.7220%15308
George Soros 2013-09-30 New Buy0.16%$32.43 - $40.86 $ 48.7232%385228
Jean-Marie Eveillard 2013-09-30 Sold Out 0.14%$32.43 - $40.86 $ 48.7232%0
John Burbank 2013-09-30 New Buy0.05%$32.43 - $40.86 $ 48.7232%40000
Ray Dalio 2013-09-30 New Buy0.01%$32.43 - $40.86 $ 48.7232%43208
John Burbank 2013-06-30 Sold Out 1.3%$30.18 - $35.82 $ 48.7246%0
Jean-Marie Eveillard 2013-06-30 New Buy0.14%$30.18 - $35.82 $ 48.7246%1438852
Charles Brandes 2013-06-30 Sold Out 0.1%$30.18 - $35.82 $ 48.7246%0
Joel Greenblatt 2013-06-30 New Buy0.05%$30.18 - $35.82 $ 48.7246%36364
John Burbank 2013-03-31 New Buy1.3%$30.64 - $34.73 $ 48.7248%988824
Joel Greenblatt 2013-03-31 Sold Out 0.1%$30.64 - $34.73 $ 48.7248%0
Charles Brandes 2013-03-31 Reduce -21.95%0.03%$30.64 - $34.73 $ 48.7248%263764
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Guru Investment Theses on Dow Chemical Co

Daniel Loeb Comments on Dow Chemical Company - Jan 22, 2014

Third Point's largest current investment is in The Dow Chemical Company (DOW)("Dow"). Dow shares have woefully underperformed over the last decade, generating a return of 46% (including dividends) compared to a 199% return for the S&P 500 Chemicals Index and a 101% return for the S&P 500.1 Indeed, in April 1999, nearly 15 years ago, an investor could have purchased Dow shares for the same price that they trade at today! These results reflect a poor operational track record across multiple business segments, a history of under-delivering relative to management's guidance and expectations, and the ill-timed acquisition of Rohm & Haas. The company's weak performance is even more surprising given that the North American shale gas revolution has been a powerful tailwind for Dow's largest business exposure – petrochemicals. 

We believe that Dow would be st serve shareholders' interests by engaging outside advisors to conduct a formal assessment of whether the current petrochemical operational strategy maximizes profits and if these businesses align with Dow's goal of transforming into a "specialty" chemic als company. The review should explicitly explore whether separating Dow's petrochemical businesses via a spin - off would drive greater stakeholder value.

From Daniel Loeb (Trades, Portfolio)'s Third Point fourth quarter 2013 commentary.

Dow's petrochemical operational strategy has been to migrate downstream , supposedly to earn higher m argins, to become more "specialty," and to increase the number of customer - facing products. Over the past five years, the shale revolution in North America has led to a boom in natural gas liquids production which has dramatically reduced raw material cos ts, while China and other emerging market economies have aggressively grown downstream derivatives capacity. This combination has led to significant upstream margin expansion in North America, where Dow is the largest ethylene producer, and a commoditizat ion of numerous downstream derivatives margins. Dow's current petrochemical strategy seems misaligned with the changed landscape.

Perhaps unsurprisingly, our analysis suggests that Dow's downstream migration strategy within petrochemicals has not yielded material benefits so far and instead may be a significant drag on profitability. We have examined Dow's aggregate petrochemical cap acities (and associated industry product margins) and compared its petrochemical cost base and profitability with pure - play peers. Our work suggests that upside from both cost - cutting and operating optimization could amount to several billion dollars in a nnual EBITDA. We suspect that Dow's push downstream has led the company to use its upstream assets to subsidize certain downstream derivatives either by sac rificing operational efficiency or making poor capital allocation decisions, or both. Poor segment disclosure combined with Dow's opaque and inconsistent transfer pricing methodology for internally sourced raw materials makes it difficult for shareholders (and presumably, the Board of Directors) to ascertain which business units are most challenged. W hat is easily ascertainable is that the magnitude of the aggregate under - earning warrants a c omprehensive strategic review , preferably with the assistance of an objective outside advisor answerable to a special committee of the Board.

We believe Dow shoul d apply the intelligent logic of its recently announced chlor - alkali separation to the entirety of its petrochemical businesses by creating a standalone company housing Dow's commodity petrochemical segments ("Dow Petchem Co . ") . 2 Such a separation would accomplish two important objectives. First, the split would accelerate 

Dow's transition to a true "specialty chemicals" company focused on attractive end - markets such as agriculture, food, pharmaceuticals, and electronics. Second, the standalone Dow Petchem Co . could realign its strategy away from largely focusing on downstream migration/integration and towards overall profit maximization.

The optimization of Dow Petchem Co . combined with the significant step - up in earnings from o rganic growth initiatives already put in place by management – the PDH plant, the Sadara JV, and the U.S. Gulf Co ast greenfield ethylene cracker – could translate into future EBITDA well in excess of $9 billion on a stand - alone basis . This would be before any improvement attributable to what management ref ers to as the "ethylene upcycle " . Both the " self - help " and cyclical upside opportunities create a compelling investment case, which is not reflected in Dow's current share price considering the entire co m pany's 2013 EBITDA base is ~$8 billion .

Despite Dow's best efforts to migrate downstream and become a specialty chemicals company, the market remains unconvinced. By creating Dow Petchem Co . , the strategic direction of these businesses would no longer b e dictated by the broader Dow strategy of becoming more specialty - focused. Instead, management could transform these businesses into a best - in - class, low - cost commodity petrochemical company.

The remaining Dow Chemical ("Dow Specialty Co . " ) 3 would be t he specialty chemicals leader that Dow has aspired to become over much of the past decade. Here too , we see meaningful upside over the coming years:

• In Dow's Agricultural Sciences segment, significant investments have been made in R&D which ha ve yet to t ranslate to profits, most notably in the development of Dow's ENLIST trait package. We are optimistic that ENLIST will be successfully adopted in the South American soybean market, where it has a natural first - mover advantage given that the 2,4 - D herbicide is approved for use in Brazil and Argentina. The South American soybean opportunity alone for ENLIST could i ncrease divisional EBITDA by 30 - 40% once fully penetrated.

• In the Electronics & Functional Materials segment, we see niches with strong e nd - market growth and high barriers to entry, leading to above - GDP growth rates and sustainably robust returns on invested capital.

• Finally, the Dow Corning JV represents a valuable call option on solar power adoption as total system costs for solar contin ue to compress and become 

increasingly competitive with other fossil - fuel electricity alternatives in much of the world. Dow Specialty Co . should command a premium to Dow's current multiple, and potentially a premium to other specialty chemicals companies given its attractive EBITDA growth prospects. T he market is skeptical of Dow's divisional margin targets given the lack of clarity around how they were derived and the lack of progress toward achieving them. However , even if management fails to attain t heir targets, we still see the potential for Dow Specialty Co . EBITDA to ramp up to the $4 - 5 billion range over the next 3 to 5 years , co mpared to a 2013 base of ~$2.8 billion .

We believe management's main concern about a spin - off of Dow Petchem Co . will likely relate to the integrated nature of Dow's overall portfolio. Importantly, the majority of the integration in Dow's portfolio exists between upstream / downstream petrochemicals and these businesses would remain together in Dow Petchem Co. In additi on , the integration between Dow Petchem Co . and Dow Specialty Co . is limited to commoditized raw material transfers. Having some amount of commoditized raw material integration does not create differentiation in specialty products nor does it materially i ncrease margins (unless the raw material inputs are being subsidized by Dow's petrochemical segments). The s egments within Dow Specialty Co . which primarily consist of legacy Rohm & Haas businesses and Dow's Agricult ural Sciences segment have successfully operated without raw material integration in the past , or have peers that are able to achieve higher margins without any raw material integration.

W e appr eciate this consideration; it is why we have contemplated a scenario in which bot h the upstream and downstream petrochemical businesses are spun - off together into Dow Petchem Co. W e believe the benefits from a spin - off, including financial uplift from operational improvements at Dow Petchem Co . and the potential valuation uplift from increased business focus and disclosure, far outweigh the supposed integration benefits.

Finally, as Dow management looks to further its journey in unlocking value for shareholders, it now ha s the balance sheet flexibility to consider a meaningful share buyback that could more than offset the share issuance from the conversion of the Warren Buffett (Trades, Portfolio)/KIA securities issued in conjunction with the financing of the Rohm & Haas acquisition. 4 Combined with th e Dow Petchem Co . spin - off, Dow c ould pave a path to ward increased disclosure, greater management accountability for individual business segment performances, and enhanced alignment of interests between management and shareholders. With the difficult task of balance sheet de - levering behind it, Dow finally has the opportunity to embark on its next transformational deal during CEO Andrew Liveris' tenure.

Check out Daniel Loeb latest stock trades

Top Ranked Articles about Dow Chemical Co

Daniel Loeb Comments on Dow Chemical Company
Third Point's largest current investment is in The Dow Chemical Company (DOW)("Dow"). Dow shares have woefully underperformed over the last decade, generating a return of 46% (including dividends) compared to a 199% return for the S&P 500 Chemicals Index and a 101% return for the S&P 500.1 Indeed, in April 1999, nearly 15 years ago, an investor could have purchased Dow shares for the same price that they trade at today! These results reflect a poor operational track record across multiple business segments, a history of under-delivering relative to management's guidance and expectations, and the ill-timed acquisition of Rohm & Haas. The company's weak performance is even more surprising given that the North American shale gas revolution has been a powerful tailwind for Dow's largest business exposure – petrochemicals.  Read more...
GuruFocus Reports Weekly Top Dividend Growers
During the past week, GuruFocus recognized five companies as dividend growers. In order to be qualified for this list, the company had to: Read more...
T Boone Pickens Increases Holdings in Four
Guru T Boone Pickens made a lot of changes to his portfolio during the second quarter. The guru sold out of six companies and in return made 20 new buys. According to his second quarter portfolio, released earlier today, Pickens now owns 39 stocks valued at $102 million. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 13.60
DOW's P/E(ttm) is ranked higher than
78% of the 808 Companies
in the Global Chemicals industry.

( Industry Median: 18.60 vs. DOW: 13.60 )
DOW' s 10-Year P/E(ttm) Range
Min: 6.31   Max: 116.67
Current: 13.6

6.31
116.67
P/B 2.50
DOW's P/B is ranked lower than
57% of the 960 Companies
in the Global Chemicals industry.

( Industry Median: 1.59 vs. DOW: 2.50 )
DOW' s 10-Year P/B Range
Min: 0.49   Max: 4.52
Current: 2.5

0.49
4.52
P/S 1.10
DOW's P/S is ranked higher than
53% of the 1000 Companies
in the Global Chemicals industry.

( Industry Median: 0.95 vs. DOW: 1.10 )
DOW' s 10-Year P/S Range
Min: 0.12   Max: 1.33
Current: 1.1

0.12
1.33
PFCF 11.00
DOW's PFCF is ranked higher than
80% of the 489 Companies
in the Global Chemicals industry.

( Industry Median: 18.82 vs. DOW: 11.00 )
DOW' s 10-Year PFCF Range
Min: 2.82   Max: 43.38
Current: 11

2.82
43.38
EV-to-EBIT 17.90
DOW's EV-to-EBIT is ranked higher than
52% of the 842 Companies
in the Global Chemicals industry.

( Industry Median: 14.88 vs. DOW: 17.90 )
DOW' s 10-Year EV-to-EBIT Range
Min: 8.4   Max: 122.2
Current: 17.9

8.4
122.2
PEG 1.50
DOW's PEG is ranked higher than
63% of the 499 Companies
in the Global Chemicals industry.

( Industry Median: 1.51 vs. DOW: 1.50 )
DOW' s 10-Year PEG Range
Min: 0.18   Max: 46.95
Current: 1.5

0.18
46.95
Shiller P/E 32.00
DOW's Shiller P/E is ranked lower than
53% of the 442 Companies
in the Global Chemicals industry.

( Industry Median: 22.21 vs. DOW: 32.00 )
DOW' s 10-Year Shiller P/E Range
Min: 2.37   Max: 41.66
Current: 32

2.37
41.66

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 2.70
DOW's Dividend Yield is ranked higher than
85% of the 755 Companies
in the Global Chemicals industry.

( Industry Median: 1.80 vs. DOW: 2.70 )
DOW' s 10-Year Dividend Yield Range
Min: 1.46   Max: 23.46
Current: 2.7

1.46
23.46
Dividend Payout 0.37
DOW's Dividend Payout is ranked higher than
66% of the 638 Companies
in the Global Chemicals industry.

( Industry Median: 0.33 vs. DOW: 0.37 )
DOW' s 10-Year Dividend Payout Range
Min: 0.29   Max: 2.71
Current: 0.37

0.29
2.71
Dividend growth (3y) 28.70
DOW's Dividend growth (3y) is ranked higher than
88% of the 431 Companies
in the Global Chemicals industry.

( Industry Median: 10.40 vs. DOW: 28.70 )
DOW' s 10-Year Dividend growth (3y) Range
Min: -28.4   Max: 28.7
Current: 28.7

-28.4
28.7
Yield on cost (5-Year) 8.17
DOW's Yield on cost (5-Year) is ranked higher than
97% of the 771 Companies
in the Global Chemicals industry.

( Industry Median: 2.03 vs. DOW: 8.17 )
DOW' s 10-Year Yield on cost (5-Year) Range
Min: 4.42   Max: 71.02
Current: 8.17

4.42
71.02
Share Buyback Rate -4.10
DOW's Share Buyback Rate is ranked higher than
58% of the 567 Companies
in the Global Chemicals industry.

( Industry Median: -1.00 vs. DOW: -4.10 )
DOW' s 10-Year Share Buyback Rate Range
Min: 5.5   Max: -10.6
Current: -4.1

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 10.20
DOW's Price/Tangible Book is ranked lower than
80% of the 927 Companies
in the Global Chemicals industry.

( Industry Median: 1.70 vs. DOW: 10.20 )
DOW' s 10-Year Price/Tangible Book Range
Min: 1.5   Max: 119.83
Current: 10.2

1.5
119.83
Price/DCF (Projected) 1.60
DOW's Price/DCF (Projected) is ranked higher than
72% of the 432 Companies
in the Global Chemicals industry.

( Industry Median: 1.40 vs. DOW: 1.60 )
DOW' s 10-Year Price/DCF (Projected) Range
Min: 0.38   Max: 2.36
Current: 1.6

0.38
2.36
Price/Median PS Value 1.40
DOW's Price/Median PS Value is ranked higher than
54% of the 927 Companies
in the Global Chemicals industry.

( Industry Median: 1.00 vs. DOW: 1.40 )
DOW' s 10-Year Price/Median PS Value Range
Min: 0.33   Max: 1.99
Current: 1.4

0.33
1.99
Price/Peter Lynch Fair Value 0.70
DOW's Price/Peter Lynch Fair Value is ranked higher than
84% of the 234 Companies
in the Global Chemicals industry.

( Industry Median: 1.10 vs. DOW: 0.70 )
DOW' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.38   Max: 6.1
Current: 0.7

0.38
6.1
Price/Graham Number 1.80
DOW's Price/Graham Number is ranked higher than
55% of the 779 Companies
in the Global Chemicals industry.

( Industry Median: 1.30 vs. DOW: 1.80 )
DOW' s 10-Year Price/Graham Number Range
Min: 1.09   Max: 7.59
Current: 1.8

1.09
7.59
Earnings Yield (Greenblatt) 5.60
DOW's Earnings Yield (Greenblatt) is ranked higher than
59% of the 886 Companies
in the Global Chemicals industry.

( Industry Median: 6.60 vs. DOW: 5.60 )
DOW' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.8   Max: 11.9
Current: 5.6

0.8
11.9
Forward Rate of Return (Yacktman) 21.41
DOW's Forward Rate of Return (Yacktman) is ranked higher than
90% of the 594 Companies
in the Global Chemicals industry.

( Industry Median: 6.16 vs. DOW: 21.41 )
DOW' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -18.8   Max: 49.4
Current: 21.41

-18.8
49.4

Business Description

Industry: Chemicals » Chemicals
Compare:BASFY, DD, SHECY, URALL, APD » details
Traded in other countries:DOW.UK, 4850.Japan, DOWB.Belgium, DOWCP.France, DOW.Switzerland, DCH1.Germany
Dow Chemical Co was incorporated in 1947 under Delaware law and is the successor to a Michigan corporation, of the same name, organized in 1897. The Company is engaged in the manufacture and sale of chemicals, plastic materials, agricultural products and services, advanced materials and other specialized products and services. It is also engaged in the property and casualty insurance and reinsurance business mainly through its Liana Limited subsidiaries. It offers a range of products and services to customers in approximately 160 countries, connecting chemistry and innovation with the principles of sustainability to help provide everything from fresh water, food and pharmaceuticals to paints, packaging and personal care products. The Company connects chemistry and innovation with the principles of sustainability to help address many of the world's challenging problems such as the need for clean water, renewable energy generation and conservation, and increasing agricultural productivity. Dow's portfolio of specialty chemical, advanced materials, agrosciences and plastics businesses deliver a range of technology-based products and solutions to customers in approximately 160 countries and in growth sectors such as electronics, water, energy, coatings and agriculture. The Company's more than 5,000 products are manufactured at 188 sites in 36 countries across the globe. Dow conducts its worldwide operations through global businesses, which are reported in eight operating segments following the acquisition of Rohm and Haas. The Company's operating segments are Electronic and Functional Materials, Coatings and Infrastructure Solutions, Agricultural Sciences, Performance Materials, Performance Plastics and Feedstocks and Energy. Dow is a manufacturer and supplier of products used mainly as raw materials in the manufacture of customer products and services. The Company serves the following industries: appliance; automotive; agricultural; building and construction; chemical processing; electronics; furniture; housewares; oil and gas; packaging; paints, coatings and adhesives; personal care; pharmaceutical; processed foods; pulp and paper; textile and carpet; utilities; and water treatment. The two raw material streams that feed the integrated production of the Company's finished goods are chlorine-based and hydrocarbon-based raw materials. Salt, natural brine and electricity is the base raw materials used in the production of chlor-alkali products and derivatives. The Company owns salt deposits in Louisiana and Texas; Alberta, Canada; Brazil; and Germany. The Company also owns limestone deposits in Texas. Other raw materials include acrylonitrile, flame retardants, aniline, bisphenol, methanol, rubber, carbon black, ammonia, formaldehyde, acetic acid and toluene diamine. The Company purchases these raw materials on both short- and long-term contracts. The Company experiences competition in each of its operating segments and in each of the

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide